Huge problem with Dodge Ram, Ford F150 and Toyota Tundra
A road safety expert has issued a warning as an influx of US-style pick up trucks rise in popularity across Australia.
Source: dailymail.co.uk
📰 Mike Sinclair News
Page 4 - Mike Sinclair News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mike Sinclair. Real-time updates on events, politics, business and more.
Addex Receives Nasdaq Notification Regarding Minimum Bid
Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, May 18, 2022 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...
United States Mike Sinclair Tim Dyer Swiss Exchange Janssen Pharmaceuticals Inc Company American Depositary Shares Adss
Source: globenewswire.com
RadioMedix and Orano Med Complete Patient Enrolment in Phase II Trial of Targeted Alpha-Emitter AlphaMedix in Neuroendocrine Cancers
Trial's Objective Response Rate Endpoint Already Achieved RadioMedix and Orano Med, two clinical stage radiopharmaceutical companies, today announced that the last patient has been dosed in the Phase
Source: finanznachrichten.de
Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study's
Cohort 1 progressing through Part 2Cohort 2 recruiting patients Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex...
United States Tim Dyer Mike Sinclair Janssen Pharmaceuticals Inc Swiss Exchange Janssen Pharmaceutical Companies Of Johnson
Source: globenewswire.com
Addex Therapeutics : Ad Hoc Announcement Pursuant to Art. 53 LR - Form 6-K
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric... | May 10, 2023
United States Mike Sinclair Tim Dyer Janssen Pharmaceuticals Inc Swiss Exchange Janssen Pharmaceutical Companies Of Johnson
Source: marketscreener.com
Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study's Independent Interim Review Committee Recommends Continuing Study
Cohort 1 progressing through Part 2Cohort 2 recruiting patients Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical... | May 10, 2023
Source: marketscreener.com
Memo Therapeutics AG Receives FDA Fast Track Designation for AntiBKV as Treatment of BKV Infection in Renal Transplant Patients
Pivotal U.S. phase II/III clinical trial has started recruiting patients AntiBKV antibody therapeutic has potential to be first- and best-in-class treatment; scheduled to be launched in 2025
Mike Sinclair Karsten Fischer Drug Administration Fast Track Chief Executive Officer Memo Therapeutics
Source: finanznachrichten.de
Addex Therapeutics: Addex Completes $5.0 Million Equity Financing
Proceeds to advance allosteric modulator therapeutic pipeline Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 5, 2023 - Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN)
United States Tim Dyer Mike Sinclair Addex Therapeutics Ltd Janssen Pharmaceuticals Inc Swiss Exchange
Source: finanznachrichten.de
Addex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson's Disease
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 4, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug... | April 4, 2023
United States Tim Dyer Mikhail Kalinichev Mike Sinclair Janssen Pharmaceuticals Inc Globenewswire Inc
Source: marketscreener.com
Diocese seeks removal of heritage status for St. Matthew's Anglican Church in Regina
St. Matthew’s Anglican Church could become a community hub in the Heritage neighbourhood. However, its heritage designation status is standing in the way of any future development plans.
Jackie Schmidt George Broder Denis Simard Mike Sinclair Trinity Centres Foundation Anglican Diocese Of Quappelle
Source: regina.ctvnews.ca